, ,
Presentations this author is a contributor to:
Impact of artificial intelligence-enabled therapy decision support on a nationwide molecular tumour board: preliminary findings of a before-after implementation study (#59)
3:00 PM
Frank P Lin
Best of the Best Orals & Closing Plenary
SPEAR: A Phase 2, Open-label, Single-arm Monotherapy Trial of Sulfasalazine in Pancreatic Adenocarcinoma – Trial in Progress (#321)
12:45 PM
Omali Pitiyarachchi
Lunch & Poster Viewing (Odd Numbers)
How do cancer survivors respond to receiving non-actionable germline genomic sequencing results? A qualitative insight. (#253)
12:45 PM
Clara Goossens
Lunch & Poster Viewing (Odd Numbers)